로딩 중…
지수 로딩 중…
Celldex Therapeutics, Inc.
CLDX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$32.42-1.55%
2026-06-18
Price Chart
Celldex Therapeutics, Inc.+55.72%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $2.54B |
| Revenue | $820000.00 |
| Net Income | $-284M |
| Total Assets | $511M |
| Net Assets | $456M |
| Value | |
| P/B | 5.58x |
| FCF Yield | -8.88% |
| Profitability | |
| ROE | -62.18% |
| ROA | -55.49% |
| Op. Margin | -37694.63% |
| Revenue Growth | -97.84% |
| Financial Health | |
| Debt Ratio | 12.06% |
| Total Debt | $2M |
| FCF | $-226M |
| Cash | $36M |
| Current Ratio | 8.92x |
| Performance | |
| 1Y Return | 55.72% |
| 1M Return | 7.53% |
| From 52W High | -9.42% |
| 1Y MDD | -24.23% |
| Trading | |
| Volume | 1,832,270 shares |
| Trading Value | $60M |
| Per Share | |
| EPS | $-3.89 |
| BPS | $7.93 |